Drugs / pralatraxate,
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03719105 | Mar 2019 → Dec 2027 expected | aggressive NK-cell leukemia | New York Medical College | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pralatraxate, | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03719105 ↗ |